LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0089U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0089U.
Elevated code risk
Signal breakdown
6 shown · 6 total in platform
Risk: Elevated
0
Critical
0%
3
High
50%
3
Routine
50%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
LCD L38178: MolDX: Pigmented Lesion Assay — WPS
Policy LCD-L38178 · Dermatology
New billing guidelines for Pigmented Lesion Assay effective soon.
LCD L38153: MolDX: Pigmented Lesion Assay — Noridian
Policy LCD-L38153 · Dermatology
New LCD affects billing for Pigmented Lesion Assay.
LCD L38151: MolDX: Pigmented Lesion Assay — Noridian
Policy LCD-L38151 · Dermatology
Prepare for changes in billing with MolDX: Pigmented Lesion Assay.
Audit documentation
Building an audit file that includes 0089U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription